Physician profile
Elizabeth Dale Weaver
NPI 1629580618
$175,965.35
in general payments reported to CMS, 2019-2025
4 companies · $166K in 2025
The $166K reported for 2025 was more than what 99% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $247 · 2022: $119 · 2023: $115 · 2024: $9,252 · 2025: $166K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $149K · Travel and Lodging: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,505 · Food and Beverage: $115 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $149,237.33 |
| Travel and Lodging | $19,652.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,504.76 |
| Food and Beverage | $115.27 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $175,394.69 | 2024-2025 | |
| Incyte Corporation | $409.00 | 2021-2024 | Monjuvi, Jakafi |
| Astellas Pharma US INC | $148.39 | 2021 | |
| Janssen Scientific Affairs, LLC | $13.27 | 2023 | Tecvayli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.